Chargement en cours...
Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis
The development and progression of non-alcoholic steatohepatitis (NASH) are linked to oxidative stress, inflammation, and fibrosis of the liver. Chymase, a chymotrypsin-like enzyme produced in mast cells, has various enzymatic actions. These actions include activation of angiotensin II, matrix metal...
Enregistré dans:
| Publié dans: | Int J Mol Sci |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7589185/ https://ncbi.nlm.nih.gov/pubmed/33066113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21207543 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|